About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 935351, 12 pages
http://dx.doi.org/10.1155/2013/935351
Clinical Study

Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors

1Medical Physics Department, European Institute of Oncology, 20141 Milan, Italy
2Medical Physics Department, IRCCS Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy
3Nuclear Medicine Department, IRCCS Arcispedale Santa Maria Nuova, 42123 Reggio Emilia, Italy
4Medical Physics Department, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, 47014 Meldola, Italy
5Medical Physics Department, Azienda Ospedaliera S. Camillo Forlanini, 00151 Rome, Italy
6Section of Radiological Sciences, Department of Biomedical Sciences and Morphologic and Functional Imaging, University of Messina, 98125 Messina, Italy
7Laboratory of Medical Physics and Expert Systems, National Cancer Institute Regina Elena, 00144 Rome, Italy
8Nuclear Medicine Department, European Institute of Oncology, 20141 Milan, Italy

Received 30 April 2013; Accepted 31 May 2013

Academic Editor: David J. Yang

Copyright © 2013 F. Guerriero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

F. Guerriero, M. E. Ferrari, F. Botta, et al., “Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors,” BioMed Research International, vol. 2013, Article ID 935351, 12 pages, 2013. doi:10.1155/2013/935351